A High THC Dose Felt Like Psilocybin. The Study Had Four People
A Johns Hopkins pilot reported 25 mg of THC produced a psilocybin-like experience. It enrolled four participants and was funded
Read More
A Johns Hopkins pilot reported 25 mg of THC produced a psilocybin-like experience. It enrolled four participants and was funded
Read More
ARPA-H's ASCENT-IBO program funds Phase 1 and 2 ibogaine trials for opioid use disorder, with patient safety up front. Solution
Read More
Bipolar patients are routinely screened out of ketamine treatment over mania risk. A midazolam-controlled trial in JAMA Psychiatry finally tested
Read More
From FDA's October 5 psychedelics docket to the DEA telehealth expiration and Medicare's 2027 in-person rule, six dates every ketamine
Read More
The American Legion adopted a resolution backing psychedelic therapy for veterans. It endorses S.4220, which would build a VA office
Read More
Israeli MDMA trials run 15 sessions over three to four months, including an eight hour dosing day with two therapists
Read More
A Science paper found psilocybin prevented chemotherapy nerve damage in mice across six treatment cycles. A non-hallucinogenic compound did the
Read More
A proposed rule would place five tryptamines into Schedule I. It is the second attempt at the same action, and
Read More
Want to help the industry understand the potential value of psychedelic therapies? Here's how to prepare for a Psychedelic Clinical
Read More
A systematic review screened 897 references on psilocybin microdosing. Of 11 studies, only two were placebo controlled, and neither found
Read More